Developer docs
API playgroundTry for free, no card

Search company profiles

Birgi Mefar Group

Full company profile

uuid000c7zc

Namestring
Birgi Mefar Group
Legal namestring
Birgi Mefar Group
Websiteurl
mefar.com
Company typeenum
Private
Founded yearint
1963
Descriptiontext

Birgi Mefar Group is a privately held, family-owned Turkish pharmaceutical Contract Development and Manufacturing Organization (CDMO) founded in 1963 by Adnan Birgi, headquartered in Istanbul with two operational subsidiaries: Birgi Sanayi A.Ş. (primary glass packaging manufacturer) and Mefar İlaç Sanayi (sterile injectable manufacturer). The group manufactures type-1 tubular glass ampoules and vials in sizes from 1 ml to 30 ml (clear and amber variants) and provides contract sterile fill-finish services across ampoules, vials, lyophilized vials, pre-filled syringes (PFS), and Blow-Fill-Seal (BFS) formats, supported by in-house R&D, laboratory services, serialization, cold chain management, and warehousing/logistics.

The company serves over 60 global and local pharmaceutical customers across 150+ different active pharmaceutical ingredients (APIs), with 40%+ of revenue derived from international markets. It holds FDA-DMF Type III filings for primary packaging products targeting the US market, Health Canada-DMF Type II filings for Canadian market access, and received EU GMP certification in December 2025 enabling broader European pharmaceutical contract manufacturing. Manufacturing operations span a 17,500 m2 closed-area sterile facility in Kurtköy, Pendik and a glass packaging facility in Samandıra, employing 650+ dedicated staff under a CXO leadership team including a CFO, CTO/Qualified Person, COO, and Chief Business Development Officer.

The business model is contract fee-based B2B sales to licensed pharmaceutical companies, with quote-based pricing rather than publicly disclosed rates. Revenue is generated through manufacturing service fees for sterile injectable production, primary packaging material sales, and ancillary services including packaging, serialization, and cold chain logistics. The go-to-market motion is sales-led and direct, targeting enterprise pharmaceutical clients through industry events, LinkedIn presence, and company website channels.

Short descriptiontext

Birgi Mefar Group is a privately held Turkish pharmaceutical CDMO founded in 1963 that manufactures type-1 tubular glass ampoules and vials and provides contract sterile injectable fill-finish services to 60+ global pharmaceutical companies across 150+ APIs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersIstanbul
HQ citystring
Istanbul
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sterile injectable manufacturing, pharmaceutical contract manufacturing, glass ampoule packaging, primary packaging manufacturing, CDMO services
Industry4 codes
PRIMARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYIMALAEAB
Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes)
SECONDARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeOthers
Description

Provides sterile pharmaceutical manufacturing services as a CDMO (Contract Development and Manufacturing Organization) to pharmaceutical companies. Revenue generated through manufacturing fees for sterile injectable products, primary packaging materials, and related services.

mefar.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Birgi Mefar Group operates as a Contract Development and Manufacturing Organization (CDMO) providing sterile injectable pharmaceutical manufacturing services through its subsidiary Mefar İlaç Sanayi, covering ampoules, vials, lyophilized vials, pre-filled syringes and Blow-Fill-Seal aseptic production, together with laboratory, packaging, serialization, cold-chain management and warehousing services. Its subsidiary Birgi Sanayi A.Ş. manufactures primary pharmaceutical packaging (empty type-1 tubular glass ampoules and vials from 1 ml to 30 ml in clear and amber variants) supplied as primary packaging material to pharmaceutical customers globally.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Birgi Mefar Group operates as a Contract Development and Manufacturing Organization (CDMO) providing integrated pharmaceutical manufacturing services. The portfolio comprises three main areas: (1) Primary glass packaging manufacturing through Birgi Sanayi A.Ş., producing empty ampoules and vials from type-1 tubular glass; (2) Sterile injectable pharmaceutical manufacturing services through Mefar İlaç Sanayi, including ampoules, vials, lyo vials, pre-filled syringes, and blow-fill-seal technology; and (3) Comprehensive support services including laboratory services, packaging, serialization, cold chain management, and warehousing & logistics. The company serves over 50 global and local pharmaceutical customers with more than 150 different raw materials.

Product and service9 records
1Empty Ampoules
CategoryPrimary Packaging Product
Description

Empty ampoules manufactured from type-1 tubular glass in sizes ranging from 1 ml to 30 ml, available in clear and amber glass variants, produced in accordance with ISO, DIN, AFNOR, BS or other specified standards. Supplied to pharmaceutical companies as primary packaging material, with FDA-DMF Type III numbers 19065 (clear) and 19066 (amber) and Health Canada-DMF Type II 2014-184.

2Empty Vials
CategoryPrimary Packaging Product
Description

Empty vials manufactured from type-1 tubular glass in sizes ranging from 1 ml to 30 ml, available in clear and amber glass variants, packaged in clean-room conditions in fiber-free cartons or PVC boxes. Supplied to pharmaceutical companies as primary packaging material, with FDA-DMF Type III numbers 19067 (clear) and 19068 (amber).

3Ampoules (Sterile Injectable)
CategoryManufacturing Service
Description

Sterile injectable pharmaceutical contract manufacturing service for ampoule products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.

4Vials (Sterile Injectable)
CategoryManufacturing Service
Description

Sterile injectable pharmaceutical contract manufacturing service for vial products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.

5Lyo Vials (Sterile Injectable)
CategoryManufacturing Service
Description

Lyophilized (freeze-dried) vial sterile injectable pharmaceutical contract manufacturing service, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.

6Pre-Filled Syringes (PFS)
CategoryManufacturing Service
Description

Sterile injectable pharmaceutical contract manufacturing service for pre-filled syringe products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.

7Blow-Fill-Seal (BFS)
CategoryManufacturing Service
Description

Advanced aseptic manufacturing technology using Blow-Fill-Seal (BFS) process for sterile pharmaceutical products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.

8Cold Chain Management
CategoryLogistics Service
Description

Temperature-controlled storage and logistics management for temperature-sensitive pharmaceutical products requiring specific handling conditions, supporting the group's sterile injectable manufacturing customers.

9Warehousing & Logistics
CategoryLogistics Service
Description

Comprehensive warehousing and logistics services including stock quarantine, release management, labelling, packaging, and serialization for pharmaceutical customers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-15
Description

Birgi Mefar Group announced partnership involvement with Arcera as part of an appointment announcement. Arcera appears to be a strategic partner in the pharmaceutical/biopharmaceutical sector.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Birgi Mefar Group

Pharmaceutical Contract Manufacturingmefar.com

Birgi Mefar Group is a privately held Turkish pharmaceutical CDMO founded in 1963 that manufactures type-1 tubular glass ampoules and vials and provides contract sterile injectable fill-finish services to 60+ global pharmaceutical companies across 150+ APIs.

What Birgi Mefar Group does

Birgi Mefar Group is a privately held, family-owned Turkish pharmaceutical Contract Development and Manufacturing Organization (CDMO) founded in 1963 by Adnan Birgi, headquartered in Istanbul with two operational subsidiaries: Birgi Sanayi A.Ş. (primary glass packaging manufacturer) and Mefar İlaç Sanayi (sterile injectable manufacturer). The group manufactures type-1 tubular glass ampoules and vials in sizes from 1 ml to 30 ml (clear and amber variants) and provides contract sterile fill-finish services across ampoules, vials, lyophilized vials, pre-filled syringes (PFS), and Blow-Fill-Seal (BFS) formats, supported by in-house R&D, laboratory services, serialization, cold chain management, and warehousing/logistics.

The company serves over 60 global and local pharmaceutical customers across 150+ different active pharmaceutical ingredients (APIs), with 40%+ of revenue derived from international markets. It holds FDA-DMF Type III filings for primary packaging products targeting the US market, Health Canada-DMF Type II filings for Canadian market access, and received EU GMP certification in December 2025 enabling broader European pharmaceutical contract manufacturing. Manufacturing operations span a 17,500 m2 closed-area sterile facility in Kurtköy, Pendik and a glass packaging facility in Samandıra, employing 650+ dedicated staff under a CXO leadership team including a CFO, CTO/Qualified Person, COO, and Chief Business Development Officer.

The business model is contract fee-based B2B sales to licensed pharmaceutical companies, with quote-based pricing rather than publicly disclosed rates. Revenue is generated through manufacturing service fees for sterile injectable production, primary packaging material sales, and ancillary services including packaging, serialization, and cold chain logistics. The go-to-market motion is sales-led and direct, targeting enterprise pharmaceutical clients through industry events, LinkedIn presence, and company website channels.

Birgi Mefar Group firmographics

Firmographics
Name
Birgi Mefar Group
Legal name
Birgi Mefar Group
Website
https://mefar.com
Company type
Private
Founded year
1963
Operating status
Operating
Headcount range
251–500 employees
Short description
Birgi Mefar Group is a privately held Turkish pharmaceutical CDMO founded in 1963 that manufactures type-1 tubular glass ampoules and vials and provides contract sterile injectable fill-finish services to 60+ global pharmaceutical companies across 150+ APIs.
Ownership category
akta.pro rank

Birgi Mefar Group industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (3391)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYIMALAEAB
Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes)
SECONDARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Sterile injectable manufacturing
  • Pharmaceutical contract manufacturing
  • Glass ampoule packaging
  • Primary packaging manufacturing
  • CDMO services

Where Birgi Mefar Group is headquartered

Location

Headquarters

HQ city
Istanbul

Offices2 records

Markets served

Birgi Mefar Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Provides sterile pharmaceutical manufacturing services as a CDMO (Contract Development and Manufacturing Organization) to pharmaceutical companies. Revenue generated through manufacturing fees for sterile injectable products, primary packaging materials, and related services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Birgi Mefar Group product offering

Product offering

Core offering

Birgi Mefar Group operates as a Contract Development and Manufacturing Organization (CDMO) providing sterile injectable pharmaceutical manufacturing services through its subsidiary Mefar İlaç Sanayi, covering ampoules, vials, lyophilized vials, pre-filled syringes and Blow-Fill-Seal aseptic production, together with laboratory, packaging, serialization, cold-chain management and warehousing services. Its subsidiary Birgi Sanayi A.Ş. manufactures primary pharmaceutical packaging (empty type-1 tubular glass ampoules and vials from 1 ml to 30 ml in clear and amber variants) supplied as primary packaging material to pharmaceutical customers globally.

Product overview

Birgi Mefar Group operates as a Contract Development and Manufacturing Organization (CDMO) providing integrated pharmaceutical manufacturing services. The portfolio comprises three main areas: (1) Primary glass packaging manufacturing through Birgi Sanayi A.Ş., producing empty ampoules and vials from type-1 tubular glass; (2) Sterile injectable pharmaceutical manufacturing services through Mefar İlaç Sanayi, including ampoules, vials, lyo vials, pre-filled syringes, and blow-fill-seal technology; and (3) Comprehensive support services including laboratory services, packaging, serialization, cold chain management, and warehousing & logistics. The company serves over 50 global and local pharmaceutical customers with more than 150 different raw materials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Empty Ampoules Empty ampoules manufactured from type-1 tubular glass in sizes ranging from 1 ml to 30 ml, available in clear and amber glass variants, produced in accordance with ISO, DIN, AFNOR, BS or other specified standards. Supplied to pharmaceutical companies as primary packaging material, with FDA-DMF Type III numbers 19065 (clear) and 19066 (amber) and Health Canada-DMF Type II 2014-184.
  • Empty Vials Empty vials manufactured from type-1 tubular glass in sizes ranging from 1 ml to 30 ml, available in clear and amber glass variants, packaged in clean-room conditions in fiber-free cartons or PVC boxes. Supplied to pharmaceutical companies as primary packaging material, with FDA-DMF Type III numbers 19067 (clear) and 19068 (amber).
  • Ampoules (Sterile Injectable) Sterile injectable pharmaceutical contract manufacturing service for ampoule products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.
  • Vials (Sterile Injectable) Sterile injectable pharmaceutical contract manufacturing service for vial products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.
  • Lyo Vials (Sterile Injectable) Lyophilized (freeze-dried) vial sterile injectable pharmaceutical contract manufacturing service, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.
  • Pre-Filled Syringes (PFS) Sterile injectable pharmaceutical contract manufacturing service for pre-filled syringe products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.
  • Blow-Fill-Seal (BFS) Advanced aseptic manufacturing technology using Blow-Fill-Seal (BFS) process for sterile pharmaceutical products, provided by Mefar İlaç Sanayi to licensed pharmaceutical customers.
  • Cold Chain Management Temperature-controlled storage and logistics management for temperature-sensitive pharmaceutical products requiring specific handling conditions, supporting the group's sterile injectable manufacturing customers.
  • Warehousing & Logistics Comprehensive warehousing and logistics services including stock quarantine, release management, labelling, packaging, and serialization for pharmaceutical customers.

Companies that use Birgi Mefar Group

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Birgi Mefar Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Birgi Mefar Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ArceraminorStrategic or Co-development Partner · 15 May 2025Birgi Mefar Group announced partnership involvement with Arcera as part of an appointment announcement. Arcera appears to be a strategic partner in the pharmaceutical/biopharmaceutical sector.

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Birgi Mefar Group competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights6 records

Customer concentration

Birgi Mefar Group social profiles

Digital presence

Birgi Mefar Group compliance and trust

Trust signal

Compliance4 records

Birgi Mefar Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Birgi Mefar Group leadership team

Management profile

Number of profiles

Profiles9 records

Birgi Mefar Group subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Birgi Mefar Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Birgi Mefar Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Birgi Mefar Group

What does Birgi Mefar Group do?

Birgi Mefar Group operates as a Contract Development and Manufacturing Organization (CDMO) providing sterile injectable pharmaceutical manufacturing services through its subsidiary Mefar İlaç Sanayi, covering ampoules, vials, lyophilized vials, pre-filled syringes and Blow-Fill-Seal aseptic production, together with laboratory, packaging, serialization, cold-chain management and warehousing services. Its subsidiary Birgi Sanayi A.Ş. manufactures primary pharmaceutical packaging (empty type-1 tubular glass ampoules and vials from 1 ml to 30 ml in clear and amber variants) supplied as primary packaging material to pharmaceutical customers globally.

Is Birgi Mefar Group a public or private company?

Birgi Mefar Group is a private company. It is classified as family owned and is currently operating.

When was Birgi Mefar Group founded?

Birgi Mefar Group was founded in 1963. It employs 251 to 500 people.

Where is Birgi Mefar Group based?

Birgi Mefar Group is headquartered in Istanbul.

How does Birgi Mefar Group make money?

One revenue line is on record: contract Manufacturing Services.

Does Birgi Mefar Group have an API?

No public API is recorded for Birgi Mefar Group.

What industry is Birgi Mefar Group in?

Birgi Mefar Group's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of IMALAEAB, Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals